标题
PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
作者
关键词
-
出版物
Cancers
Volume 15, Issue 18, Pages 4471
出版商
MDPI AG
发表日期
2023-09-08
DOI
10.3390/cancers15184471
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas
- (2023) Mengwu Shi et al. Frontiers in Endocrinology
- Overview of the 2022 WHO Classification of Pituitary Tumors
- (2022) Sylvia L. Asa et al. ENDOCRINE PATHOLOGY
- Clinical Biology of the Pituitary Adenoma
- (2022) Shlomo Melmed et al. ENDOCRINE REVIEWS
- Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
- (2022) Mirela Diana Ilie et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours
- (2021) John Turchini et al. ENDOCRINE PATHOLOGY
- Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section
- (2021) Sam Ng et al. ACTA NEUROCHIRURGICA
- Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
- (2021) Sylvia L. Asa et al. MODERN PATHOLOGY
- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
- (2020) Shinsuke Uraki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genomic and molecular characterization of pituitary adenoma pathogenesis: review and translational opportunities
- (2020) Mazin Elsarrag et al. Neurosurgical Focus
- Primary and Ipilimumab-induced Hypophysitis: A Single-center Case Series
- (2020) Paul Atkins et al. ENDOCRINE RESEARCH
- Analysis of Cyclooxygenase 2, Programmed Cell Death Ligand 1, and Arginase 1 Expression in Human Pituitary Adenoma
- (2020) Guodong Zhao et al. World Neurosurgery
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management
- (2019) Daniela Esposito et al. Pituitary
- Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
- (2019) Mizuto Sato et al. Journal of Clinical Medicine
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- Definition and diagnosis of aggressive pituitary tumors
- (2019) Leandro Kasuki et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Combined modalities of surgery, radiotherapy, radiosurgery and chemotherapy for invasive pituitary carcinoma
- (2018) Constantin Tuleasca et al. ANNALES D ENDOCRINOLOGIE
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas
- (2018) M. Lisa Zhang et al. MODERN PATHOLOGY
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diagnosis and Treatment of Pituitary Adenomas
- (2017) Mark E. Molitch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
- (2017) Andrea B. Apolo et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
- (2017) Valentina Audrito et al. Oncotarget
- Coinhibitory Pathways in Immunotherapy for Cancer
- (2016) Susanne H. Baumeister et al. Annual Review of Immunology
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients
- (2016) Marialaura Del Basso De Caro et al. NEUROSURGICAL REVIEW
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
- (2015) Xiangjiao Meng et al. CANCER TREATMENT REVIEWS
- Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
- (2015) Alexander S. G. Micko et al. JOURNAL OF NEUROSURGERY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights
- (2015) Alexander Faje Pituitary
- Invasive adenoma and pituitary carcinoma: a SEER database analysis
- (2014) Tara M. Hansen et al. NEUROSURGICAL REVIEW
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Classification accuracy and cut point selection
- (2012) Xinhua Liu STATISTICS IN MEDICINE
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
- (2011) Pamela U. Freda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Pathogenesis of pituitary tumors
- (2011) Shlomo Melmed Nature Reviews Endocrinology
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation